Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-13

Clinical Trial Update: Bladder Cancer Adjuvant Radiotherapy Trial [Phase 3]

View source ↗

Summary

An ongoing Phase 3 adjuvant radiotherapy trial in bladder cancer (urothelial carcinoma of the bladder) is currently active but not recruiting, sponsored by Tata…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Tata Memorial Centre | Conditions: Bladder Cancer, Urothelial Carcinoma Bladder | Phase 3 | Status: ACTIVE_NOT_RECRUITING